EMA — authorised 15 February 2016
- Marketing authorisation holder: Eli Lilly Nederland B.V.
- Status: approved
🇪🇺 Portrazza in European Union
EMA authorised Portrazza on 15 February 2016
Marketing authorisation
Portrazza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Portrazza approved in European Union?
Yes. EMA authorised it on 15 February 2016.
Who is the marketing authorisation holder for Portrazza in European Union?
Eli Lilly Nederland B.V. holds the EU marketing authorisation.